There's plenty of work on offer for IDT without winning the government mRNA contract outright.
The MIPS deal could transform the company but will take time to happen.
Medical cannabis products hold some promise, though I don't rate them as transformational.
Winning any part of the supply chain for the government mRNA winner would be huge.
In my view, the Aussie government has learned a tough lesson on pharmaceutical supply during the pandemic. The fact that they have reached out to IDT indicates to me that they want to ensure companies like IDT remain viable in the long term This will be very positive for IDT going forward.
IDT media thread, page-370
-
- There are more pages in this discussion • 390 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.50M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 373166 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 83792 | 5 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| IDT (ASX) Chart |
Day chart unavailable